$crsp - consolidation continues...I expect this to consolidate for the next few weeks.. probably into Q1/Q2 2022... leading to an eventual breakout to retest ATH
CRSP/N trade ideas
CRISPR Therapeutic needs to break 83.46. This is a critical testCrispr has been moving up since the Morning star break out on 13th December. Its further progress hinges on breaking the 83.46 resistance. It has tried piercing this resistance twice but failed. The resistance line at 83.46 and the upward support channel formed since 14th December at $70.37 is intersecting 83.46 on 28th December and CRSP has to break out before that to make any further progress. Option strategies can be deployed to exploit the opportunity either way.
nice downtrend break here! looking for a rally now 🍿fresh breakout past a 5 month downtrend on CRSP ! if it holds and doesn't break back into the trend potential price targets for early 2022 area 98.31-113.89-129.47
like and follow for more 💘
CRSPCRSP It's time to update the idea. The care turned out to be very deep, although this option of leaving for zone 77 was supposed. Now we have dropped out of the channel a little, we will count for an error, we are also holding on to the ema200 during the week, we have formed hidden divergences during the week, taking into account the potential of the company, the growth of xbi and the VRTX partner may be interesting.
It may still come down and test the "trend", but we are already at a good level
50sma is the next resistanceBroke through the yellow downward trendline today with volume. The 50sma coincides with my gray trendline. Big upside if it can break through that.
Time to buy CRSPCatalysts coming in 2022 and weekly trend changes based on heiken ashii candles, plus the bounce at 74+- which was prior resistance, plus analyst ratings make this an attractive buy for me at these levels.
CRSP on a major weekly level. What's coming next? Today we will take a look at CRISPR Therapeutics.
Which are the main technical elements we can see here?
a) The price is against a major Support/Resistance level, working since 2018. The price reaction on these zones tends to provide solid insight into future movements.
b) Let's assume the price bounces on the current zone; what can we expect?
- A movement towards the descending trendline around 100.00. IF that happens, that would be a take-profit level for me. Why? Because we tend to observe corrections once the price reaches a major level. You don't want to be insight a sideways movement for 100 days
c) Let's assume that the price breaks the current level and keeps falling. What can we expect?
- A movement towards the ascending trendline around 50.00. That would be the next level where I would start thinking again about bullish reversals.
d) I'm a position trader. What is the most relevant level right now to develop setups?
-If that's your case, I want to see first a breakout of the descending trendline; IF that happens, I want to see a correction of around 50 days. IF that is the case, I will be interested in trading that breakout for the long term. However, at the moment, we are far away from that situation, and I would stay away from this chart for long-term setups.
Thanks for reading! Feel free to share your view of this in the comments.
CRISPR BUY OR NOT TO BUY..?Third Quarter 2021 Financial Results
• Cash Position: Cash, cash equivalents, and marketable securities were $2,477.4 million as of
September 30, 2021, compared to $2,589.4 million as of June 30, 2021. The decrease in cash of
$112.0 million was primarily driven by cash used in operating activities to support ongoing
research and development of the Company’s clinical and pre-clinical programs.
• Revenue: Total collaboration revenue was $0.3 million for the third quarter of 2021, compared to
$0.1 million for the third quarter of 2020. Collaboration revenue primarily consisted of revenue
recognized in connection with our collaboration agreements with Vertex.
• R&D Expenses: R&D expenses were $105.3 million for the third quarter of 2021, compared to
$71.0 million for the third quarter of 2020. The increase in expense was driven by the development
activities supporting the advancement of the hemoglobinopathies program and wholly-owned
immuno-oncology programs, as well as increased headcount and supporting facilities, related
expenses.
• G&A Expenses: General and administrative expenses were $24.4 million for the third quarter of
2021, compared to $21.5 million for the third quarter of 2020. The increase in general and
administrative expenses for the year was primarily driven by headcount-related expenses.
• Net Loss: Net loss was $127.2 million for the third quarter of 2021, compared to a net loss of
$92.4 million for the third quarter of 2020.
crisprtx.gcs-web.com
MACD: BEARISH CROSS
RSI: OVERSOLD
VOLUME: LOW
CURRENT SUPPORT @ 1.272 FIB
1.618 IS YOUR IMPULSE TARGET FOR A BREAK IN EITHER DIRECTION
Puzzled on this one honestly, looks like it wants to go lower, but we'll see at the weekly close. Keep an eye on the SPY index.
DYOR
PRACTICE RISK MANAGEMENT
GOOD LUCK
Return to the mean-Covid ignored. We returned to the mean.
-Purple area = consolidation zone = buy zone.
CRISPR is a truely amazing discovery. Imagine if we could perfectly edit genes within 5 or 10 years. I don't think everyone understands how big this is. Good luck! Target 1 = double top, other 2 the fibonacci extensions.
Edit: Don't buy before we stay above the 20MA.
CRSP Possible BottomCRSP is currently at key support and the 200 week moving average. This may be a possible bottom, however it is best to look for an entry on a lower time frame (4hr or 1hr chart) before entering. Bottoming patterns to look out for are inverted head and shoulders, double bottoms, and/or higher highs with higher lows.
CRSP - WEDGE ON SUPPORT - PIVOT CANDLE CONFORMATION **ON ALERT**All,
Pretty easy to see why you would be bullish here. Few things need to happen.
1) full candle break watch for a gap etc
2) needs to break horizontal SR at 81.50s (full candle above)
3) market needs to hold this in here if it were to somehow lose these yellow levels would be big downside imo.
Add alerts and keep this on a short timeline maybe literally one more day.
CRSP: 45, then LongThat was a nasty double top on the monthly time frame.weve come this far and we are over sold but we may come all the way down to the main support. Comforting as well to see volume increasing and picking up again recently.
Over sold on multiple indicatora.
Not trading advice.
$CRSP RSI Oversold; Expecting Bounce to $105Historically everytime RSI was this oversold, stock had a nice bounce/run ~ based on history expect a bounce to to $105 /// Additionally $75 seems like a strong support...I think bottom is in - I'm long Dec & Jan calls / not financial advice do your own research NASDAQ:CRSP
CRSP Falling Wedge/RetestCRSP looks to be retesting the breakout to all time highs while forming a falling wedge. If this level holds it could be a good entry point. Wont be jumping on this anytime soon but interested in the setup will be watching.
CRSP CRISPR Therapeutics at 52 Week LowCRSP CRISPR Therapeutics 52 Week Range 77.42 - 220.20
Now the price is 80.08usd.
Bounced from its last support level.
Barclays has a price target o 148usd for it.
My price target by Q1 2022 is the 100usd resistance.
Looking forward to read your opinion about it.
CRISPR lookin readyIf crispr can hold support over the next few weeks, we could see some nice returns.
The weekly shows a falling wedge pattern with class a bullish divergence maturing.
A move to the .618 could mean nice gains.
This thing's going higher imo SWING IDEA
I like Crsp as a long stock hold but i always think the two week outlook on this thing is huge, price targets in post but gosh darn i like it all bullish signals
Godbless, safe trading to all bulls and bears
-nio_to_da_moon225
CRSP ANALYSISCRSP broke its trend line to the downside coming out of a head and shoulder pattern, has a bullish regular divergence. There is chance to broke to the next level of $80 where it has found resistance in the past, but divergence indicates that it probably continue to consolidating and then broke to the upside. It has found resistance at these levels in the past more then 3 times which indicates is a strong level of resistance. It's sitting at the golden zone level at the fibonacci, usually a good point for stocks to turn over. I hope it is helpful to someone. Not financial advice, thanks for the feedback!
CRSP rompió su línea de tendencia a la baja saliendo de un patrón de cabeza y hombros, tiene una divergencia regular alcista. Existe la posibilidad de romper al siguiente nivel de $ 80 donde ha encontrado resistencia en el pasado, pero la divergencia indica que probablemente continúe consolidándose y luego rompió al alza. Ha encontrado resistencia en estos niveles en el pasado más de 3 veces, lo que indica un fuerte nivel de resistencia. Se encuentra en el nivel de la zona dorada en el fibonacci, generalmente un buen punto para que las acciones cambien de direccion. Espero y le sea util a alguien. No es un consejo financiero, gracias por la retroalimentacion!
CRSP is bullish here, build up is enough to overcome downtrendCRSP is bullish here, build is enough to overcome downtrend
RSI has been progressively gaining momentum
CRSP Crispr Trend Change PossibleThis is a daily chart of CRSP. As you can see, I marked the areas where high volume has occurred in the past. It's a little hard to see as I had to make the vertical lines almost transparent so you could see the candle and the volume I marked.
In every recent case a high volume daily candle has marked a trend change. This may not be the case now, but from the looks of it, it would hard to be short after the bulls stepping up like this during a down trend.
Pull Back FishingCRSP gapped down yesterday. The candle it gapped down on closed green and quite a bit higher than the day's low. There was also a pocket pivot, a large money footprint, that formed even though negative volume is on the low side. Someone or some folks, did not want to see this go lower or they took advantage of the lower price. Obviously, a lot of shares were purchased on the gap down yesterday.
Price was below the lower band set on 80. Price eventually returns to the bands.
Short interest is 3.84%.
Biotech has been a struggle and this could go lower. I would think these buyers will come back in before it fell too much as evidenced by yesterday's reaction to the gap down.
The moving averages need a lot of work )o:
No recommendation/earnings 10-27 after market close
CRSP look below 97 and fail, strong support level.NASDAQ:CRSP
The lines represent the price level that has been traded upon or will be traded.
The more it hit the line, the stronger the level.
It can be use to set profit taking price or stop loss price.
Every level is of same significant until order flow trades upon it.
DYODD.
